乾眼症治療市場規模、佔有率、成長分析、按類型、藥物、產品、劑型、銷售管道、地區 - 產業預測，2025-2032 年

2023 年全球乾眼症治療市場規模價值 70.7 億美元，預計將從 2024 年的 75.6 億美元成長到 2032 年的 130 億美元，預測期內（2025-2032 年）的複合年成長率為 7.0%。

由於乾眼症盛行率上升和人口老化，全球乾眼症治療市場正在經歷強勁成長。意識的增強、診斷工具的技術進步以及對患者舒適度的關注正在推動市場擴張。主要治療選擇是藥物干預，如人工淚液、抗發炎藥物和免疫調節劑。此外，再生醫學和基因療法等創新治療方法也越來越受到青睞，有望解決乾眼症的根本原因。隨著研發的不斷深入，市場將持續成長，提高治療效果並改善病患的治療效果。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 宏觀經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術分析
• 貿易分析

乾眼症治療市場規模（按類型）

• 市場概況
• 蒸發性乾眼症
• 淚液缺乏性乾眼症

乾眼症治療市場規模（依藥物類型）

• 市場概況
• 汐多拉
• 雷斯塔西斯
• 塞誇
• 蒂亞
• 阿塞維斯
• 其他

乾眼症治療市場規模（依產品分類）

• 市場概況
• 人工淚液
• Cyclosporine
• 局部皮質類固醇
• 淚點塞
  • 可拆卸的
  • 溶解度
• 口服歐米茄補充劑
• 其他

乾眼症治療市場規模（以劑型）

• 市場概況
• 眼藥水/溶液
• 軟膏和凝膠
• 膠囊和藥片（用於補充劑）
• 其他劑型

乾眼症治療市場規模（依銷售管道）

• 市場概況
• 處方箋
• 在商店
• 其他

乾眼症治療市場規模（依分銷管道分類）

• 市場概況
• 零售藥局
• 醫院藥房
• 網路藥局

乾眼症治療市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Novartis AG（Switzerland）
• AbbVie Inc.（USA）
• Sun Pharmaceutical Industries Ltd.（India）
• Santen Pharmaceutical Co. Ltd.（Japan）
• AFT Pharmaceuticals（New Zealand）
• Johnson & Johnson Services, Inc.（USA）
• Otsuka Pharmaceutical Co. Ltd.（Japan）
• OASIS Medical（USA）
• Bausch Health Companies Inc.（Canada）
• Alcon Inc.（Switzerland）
• Akorn Operating Company LLC（USA）
• Alimera Sciences（USA）
• GlaxoSmithKline plc（UK）
• Nicox SA（France）
• Novaliq GmbH（Germany）
• Horus Pharma（France）
• Mitotech（Russia）
• Prestige Consumer Healthcare（USA）
• Sentiss Pharma Pvt. Ltd.（India）
• VISUfarma（Netherlands）

結論和建議

Global Dry Eye Syndrome Treatment Market size was valued at USD 7.07 billion in 2023 and is poised to grow from USD 7.56 billion in 2024 to USD 13.0 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

The global dry eye syndrome treatment market is experiencing robust growth, driven by the rising prevalence of the condition and an aging population. Increased awareness, coupled with technological advancements in diagnostic tools, and a focus on patient comfort, are propelling market expansion. The primary treatment options remain pharmaceutical interventions, such as artificial tears, anti-inflammatory drugs, and immunomodulators. Additionally, there's a growing trend towards innovative therapies, including regenerative medicine and gene therapy, which hold promise for addressing the root causes of dry eye syndrome. As research and development efforts intensify, the market is poised for continued growth, enhancing treatment efficacy and improving patient outcomes in the years ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Dry Eye Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Dry Eye Syndrome Treatment Market Segmental Analysis

Global Dry Eye Syndrome Treatment Market is segmented by Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel and region. Based on Type, the market is segmented into Evaporative Dry Eye Syndrome and Aqueous Deficient Dry Eye Syndrome. Based on Drugs, the market is segmented into Xiidra, Restasis, Cequa, Tyrvaya, Eysuvis and Others. Based on Product, the market is segmented into Artificial Tears, Cyclosporine, Topical Corticosteroids, Punctal Plugs, Oral Omega Supplements and Others. Based on Dosage Form, the market is segmented into Eye Drops/ Solutions, Ointments and Gels, Capsules & Tablets (For Supplements) and Other Dosage Forms. Based on Sales Channel, the market is segmented into Prescription, OTC and Others. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Dry Eye Syndrome Treatment Market

The global dry eye syndrome treatment market is experiencing significant growth driven by several factors contributing to the rising incidence of dry eye syndrome (DES) worldwide. Increased screen time associated with digital technology usage, an aging population, environmental pollution, and changing lifestyles have all significantly heightened the occurrence of DES. Consequently, this has led to a surge in demand for effective and innovative treatment solutions such as artificial tears, anti-inflammatory medications, and punctal plugs. This growing awareness and need for advanced therapeutic options are crucial in facilitating the expansion of the dry eye syndrome treatment market on a global scale.

Restraints in the Global Dry Eye Syndrome Treatment Market

The global dry eye syndrome treatment market faces a significant challenge due to the absence of a universal treatment solution. This condition is multifaceted, with various underlying causes such as aqueous deficiency and evaporative dysfunction, which results in a wide disparity in treatment effectiveness among patients. This variability often leads to extensive trial and error for individuals, causing frustration and delays in achieving relief. Furthermore, the complexity of dry eye syndrome complicates the pharmaceutical industry's efforts to create new therapies tailored to the distinct needs of each patient, ultimately hindering the potential growth of the market.

Market Trends of the Global Dry Eye Syndrome Treatment Market

The Global Dry Eye Syndrome Treatment market is increasingly shifting towards preservative-free eye drops and artificial tears, driven by a heightened awareness of the adverse effects associated with conventional preservatives. This trend reflects a broader consumer demand for safer, more effective therapeutic options that minimize irritation and enhance comfort for patients suffering from this chronic condition. As a result, pharmaceutical companies are investing in the development of innovative preservative-free formulations, aligning with patient preferences and regulatory pushes for safer healthcare products. Additionally, this trend is bolstered by the rising incidence of dry eye syndrome due to lifestyle factors, creating a robust market opportunity.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis
• Trade Analysis

Global Dry Eye Syndrome Treatment Market Size by Type & CAGR (2025-2032)

• Market Overview
• Evaporative Dry Eye Syndrome
• Aqueous Deficient Dry Eye Syndrome

Global Dry Eye Syndrome Treatment Market Size by Drugs & CAGR (2025-2032)

• Market Overview
• Xiidra
• Restasis
• Cequa
• Tyrvaya
• Eysuvis
• Others

Global Dry Eye Syndrome Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Artificial Tears
• Cyclosporine
• Topical Corticosteroids
• Punctal Plugs
  • Removable
  • Dissolvable
• Oral Omega Supplements
• Others

Global Dry Eye Syndrome Treatment Market Size by Dosage Form & CAGR (2025-2032)

• Market Overview
• Eye Drops/ Solutions
• Ointments and Gels
• Capsules & Tablets (For Supplements)
• Other Dosage Forms

Global Dry Eye Syndrome Treatment Market Size by Sales Channel & CAGR (2025-2032)

• Market Overview
• Prescription
• OTC
• Others

Global Dry Eye Syndrome Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Dry Eye Syndrome Treatment Market Size & CAGR (2025-2032)

• North America (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • US
  • Canada
• Europe (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Drugs, Product, Dosage Form, Sales Channel, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AFT Pharmaceuticals (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co. Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Akorn Operating Company LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alimera Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nicox S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novaliq GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horus Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitotech (Russia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prestige Consumer Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sentiss Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VISUfarma (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations